Jim Cramer recommending AbbVie Inc. for long-term investors, despite stock drop

From Yahoo Finance: 2025-05-16 15:09:00

Jim Cramer praised AbbVie Inc. as one of his top picks, citing its strong franchises in various medical fields. The stock dropped 10 points due to a bond market selloff, but still offers a 3.7% yield. Despite rising rates, AbbVie remains a safe bet in the pharmaceutical sector.

AbbVie Inc. is a pharmaceutical company known for its wide range of medicines. While it has growth potential, some believe that other AI stocks offer better returns with less risk. For those seeking a promising AI stock with 100x upside potential, consider exploring alternative options beyond AbbVie.



Read more at Yahoo Finance: Makes “Sense To Start a Position in the Stock”